Financials LIMES Schlosskliniken AG Deutsche Boerse AG
Equities
LIK
DE000A0JDBC7
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
336 EUR | +1.20% | -0.59% | +19.15% |
13/05 | LIMES Schlosskliniken AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
06/02 | LIMES Schlosskliniken AG Provides Earnings Guidance for the First Half and Year 2024 | CI |
Valuation
Fiscal Period: December | 2020 | 2021 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Capitalization 1 | 29.91 | 60.4 | 100.9 | - | - |
Enterprise Value (EV) 1 | 29.91 | 60.4 | 100.9 | 100.9 | 100.9 |
P/E ratio | -43 x | 15.3 x | - | - | - |
Yield | - | - | - | - | - |
Capitalization / Revenue | - | - | 2.33 x | 1.8 x | 1.53 x |
EV / Revenue | - | - | 2.33 x | 1.8 x | 1.53 x |
EV / EBITDA | - | - | 9.38 x | 7.25 x | 6.14 x |
EV / FCF | - | - | - | - | - |
FCF Yield | - | - | - | - | - |
Price to Book | - | - | - | - | - |
Nbr of stocks (in thousands) | 293 | 293 | 293.2 | - | - |
Reference price 2 | 102.0 | 206.0 | 344.0 | 344.0 | 344.0 |
Announcement Date | 14/05/21 | 29/04/22 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net sales 1 | - | - | 43.29 | 55.98 | 66.12 |
EBITDA 1 | - | - | 10.75 | 13.91 | 16.43 |
EBIT 1 | - | - | 6.963 | 10.81 | 13.03 |
Operating Margin | - | - | 16.09% | 19.3% | 19.7% |
Earnings before Tax (EBT) | - | - | - | - | - |
Net income | -0.6944 | 3.944 | - | - | - |
Net margin | - | - | - | - | - |
EPS | -2.370 | 13.45 | - | - | - |
Free Cash Flow | - | - | - | - | - |
FCF margin | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 14/05/21 | 29/04/22 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Net Debt | - | - | - | - | - |
Net Cash position | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - |
Assets | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - |
Capex | - | - | - | - | - |
Capex / Sales | - | - | - | - | - |
Announcement Date | 14/05/21 | 29/04/22 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.39% | 1.56TCr | |
-2.70% | 1.17TCr | |
+2.65% | 1.16TCr | |
+2.37% | 1.01TCr | |
+29.48% | 869.89Cr | |
-10.45% | 715.53Cr | |
+8.05% | 684.58Cr | |
+3.94% | 570.56Cr | |
+13.33% | 429.78Cr |
- Stock Market
- Equities
- LIK Stock
- LIK Stock
- Financials LIMES Schlosskliniken AG